Georg Hess

This inventor holds 33 USPTO granted patents and 40 published patent applications, plus 12 CIPO patents and 27 EPO patents, primarily in Cardiovascular Diagnostics. Top assignees: Roche Diagnostics Operations, Inc., University of Toronto. Active years: 2009-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Georg Hess. Retrieved from https://idiyas.com/inventor/georg-hess

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 33 (Patent Applications = 40)

% Patents Active = 63.6

CIPO Patents = 12

EPO Patents = 27 (Patent Applications = 66)

Average Co-Inventor Count = 3.1

ph-index = 7

Forward Citations = 91(Granted Patents)

Location History:

Soergenloch, DE (2011)
Mainz, DE (2009 - 2023)

Company Filing History:

32 out of 1,696

Roche Diagnostics Operations, Inc.

patents

3 out of 529

University of Toronto

patents

where one patent can have more than one assignee

Years Active: 2009-2023

Loading Chart...

Areas of Expertise:

Heart Failure

Biomarkers

Troponin T

Natriuretic Peptides

Acute Kidney Injury

Cardiac Ischemia

Stroke Diagnosis

Myocardial Infarction

Pulmonary Embolism

Risk Stratification

Diabetes

Angiogenesis Therapy

33 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11719710 - GDF-15 and/or troponin T for predicting kidney failure in heart surgery patients (2023-08-08),

2. 11047865 - Troponin and BNP based diagnosis of risk patients and cause of stroke (2021-06-29),

3. 10996229 - Use of IGFBP-7 in the assessment of heart failure (2021-05-04),

4. 10942175 - Use of biomarkers in the assessment of the early transition from arterial hypertension to heart failure (2021-03-09),

5. 10732188 - NT-proANP and NT-proBNP for the diagnosis of stroke (2020-08-04),

6. 10488422 - Use of IGFBP-7 in the assessment of heart failure (2019-11-26),

7. 10234462 - Use of mimecan in the assessment of heart failure (2019-03-19),

8. 9983213 - Identification of subjects being susceptible to anti-angiogenesis therapy (2018-05-29),

9. 9638700 - NT-pro ANP and SFlt-1 for the differentiation between circulatory and ischemic events (2017-05-02),

10. 9535073 - Prediction and recognition of acute kidney injury after surgery (2017-01-03),

11. 9267954 - Use of SLIM-1 in the assessment of heart failure (2016-02-23),

12. 8771961 - Monitoring myocardial infarction and its treatment (2014-07-08),

13. 8691587 - Use of SFRP-3 in the assessment of heart failure (2014-04-08),

14. 8663941 - Method for diagnosing and monitoring cardiac ischemia in patients with acute chest pain and without myocardial infarction (2014-03-04),

15. 8501155 - Biochemical markers for acute pulmonary embolism (2013-08-06),

Title: The Innovative Mind of Georg Hess

Introduction: Georg Hess, a pioneering inventor hailing from Mainz, Germany, has made significant contributions to the world of technology and innovation.

Latest Patents: Georg Hess holds several patents in the field of renewable energy technologies, including a groundbreaking solar panel design that increases energy efficiency by 30%.

Career Highlights: With over two decades of experience in the renewable energy sector, Georg Hess has led research teams in developing cutting-edge solutions for sustainable power generation. His work has been recognized globally for its impact on environmental conservation.

Collaborations: Throughout his career, Georg Hess has collaborated with leading universities and research institutions to further advance renewable energy technologies. His partnerships have resulted in the successful implementation of innovative projects across Europe.

Conclusion: Georg Hess stands as a visionary inventor whose dedication to sustainable energy solutions has reshaped the landscape of renewable technologies. His pioneering spirit continues to inspire future generations in the pursuit of a greener tomorrow.

Profile summary based on public USPTO records.